In the latest post of President’s Blog, ASAM Acting President Dr. Stuart Gitlow asks why addiction medications like buprenorphine have dosage and patient limits. These medications are reasonably safe, nearly impossible to overdose on and have a lower street value than other narcotics, in comparison to dozens of opioids and sedative-hypnotics that can be prescribed without any apparent limitations.
Click here to read the blog post.